Categories: Science

Experts Say Standard Genetic Testing Might Be Cost Effective For Newly Diagnosed Patients With GIST

Scientists have said that a standard gene testing for patients who have been diagnosed with metastatic gastrointestinal stromal tumors (GIST) will be more cost-effective. They have said that the financial estimate will support the widespread adoption of this approach. A study of genetic tests and modified first-line cure shows that using genetic testing to match the treatment of KIT differences to the imatinib dose is a less expensive way as compared to empirical imatinib. Experts have said that genetic test helps doctors to give chemotherapy in a tumor-specific way. In this case, those patients who do not get any relief from imatinib are given the alternative cure. This study has been published in JAMA Network Open.

The author of the study, David Geffen has said that genetic test is cheap as it avoids futile treatment and low rates of disease growth. He has made a Markov model to match the efficiency of the targeted gene test and modified first-line therapy with imatinib therapy in patients with GIST. The key factor for assessing the cost efficiency of the gene test has been quality of life years (QALY). The cost-efficiency of gene testing is defined by the incremental cost-effectiveness ratio. An incremental cost-effectiveness ratio, which is less than $100000, is considered cost-effective. As per the study, a therapy directed by the gene test is linked with an increase of 0.10 QALYs, at $9513 as compared to empirical imatinib. It leads to an incremental cost-effectiveness ratio of $92100. However, experts have said that the findings are sensitive to the costs of targeted gene tests, drugs, and health utility model efforts.

Experts have said that 70 percent of times, a targeted gene test is quite cost-efficient. The results of the study show that therapy directed by targeted gene tests can be cheaper if it gets hold of more share in the market, as of now imatinib therapy has a larger market share. Experts have advised patients with newly detected GIST that they should go for genetic testing before the start of first-line chemotherapy. They have said that this way patients who do not get any relief from imatinib, can be given a better treatment for their lumps. Experts have said that there is a need for further studies to substantiate the findings.

Ketan Mahajan

Recent Posts

Epoxy Composites Market Is Encouraged To Reach USD 80.8 Billion by 2033 at a CAGR of 7.7%

Introduction The global Epoxy Composites Market is poised for robust growth, expected to expand from…

4 months ago

Hydrotreating Catalyst Market To Reach USD 4.3 Billion by 2033 | CAGR 4.5%

Introduction The global Hydrotreating Catalyst Market is experiencing significant growth and is projected to reach…

4 months ago

Phosphates Market Expected To Reach USD 64 Billion in 2033, Set To Surge with a 2.7% CAGR

Introduction The global Phosphates Market is poised for steady growth, with its size expected to…

4 months ago

Redispersible Polymer Powder Market Expected To Reach USD 5 Billion in 2033, Set To Surge with a 6.3% CAGR

Introduction The global Redispersible Polymer Powder Market is projected to experience significant growth over the…

4 months ago

Copper Clad Laminates Market Size To See Promising Growth | Projected at USD 29.6 Billion by 2033

Introduction The global Market for Copper Clad Laminates (CCL) is poised for substantial growth, with…

4 months ago

Cosmetic Emulsifier Market Is Encouraged To Reach USD 1298 Million by 2033 at a CAGR of 6.9%

Introduction The global Cosmetic Emulsifier Market is anticipated to expand significantly from USD 712 Million…

4 months ago

Water Clarifiers Market Growth (USD 12.5 Billion by 2033 at 6.0% CAGR) Global Analysis by Market.us

Introduction The global Water Clarifiers Market is projected to expand from USD 7.4 Billion in…

5 months ago

Particle Board Market Is Expected To Reach USD 34.8 Billion By 2033 | CAGR 3.7%

Introduction The global Particle Board Market, valued at USD 24.2 Billion in 2023, is anticipated…

5 months ago

Trenchless Pipe Rehabilitation Market Growth (USD 16.7 Bn by 2033 at 6.3% CAGR) Global Analysis by Market.us

Introduction According to Market.us, The global Trenchless Pipe Rehabilitation Market is poised for significant expansion,…

5 months ago

Geohazard Market Size Is To Grow at a CAGR of 5.2%

Introduction The global Geohazard Market, focused on assessing and mitigating geological risks such as earthquakes,…

5 months ago

Non Alcoholic Tequila Market Growth (USD 207.4 Mn by 2033 at 9.0% CAGR) Global Analysis by Market.us

Introduction The Global Non-Alcoholic Tequila Market is poised for significant growth, anticipated to expand from…

5 months ago

Butyl Methacrylate Market Size to Reach USD 449.6 Million by 2033 – Rise with Steller CAGR 10.7%

Introduction The global Butyl Methacrylate (BMA) Market, with its broad scope of application across key…

5 months ago

Bio Butanol Market To Offer Numerous Opportunities At a CAGR Of 8.3% Through 2033

Introduction The global Bio-Butanol Market is set for significant expansion, with projections suggesting growth from…

5 months ago

Hybrid Composites Market to Reach USD 3277.4 Million Globally by 2033 at a CAGR of 15.1%

Introduction The global Hybrid Composites Market is poised for robust growth, projected to expand from…

5 months ago

Global Polyhydroxyalkanoate (PHA) Market Size To Exceed USD 389.2 Million By 2033 | CAGR Of 12.2%

Introduction The Polyhydroxyalkanoate (PHA) Market is poised for substantial growth over the next decade, driven…

5 months ago

PMMA Recycling Market is Projected to Expand at a Robust CAGR of 6.73% of 2033

Introduction The PMMA Recycling Market is poised for significant expansion from 2023 to 2033, with…

5 months ago

Reflective Polarizing Films Market is Estimated to Grow at a CAGR of 19.3 % between 2023 to 2033

Introduction The Global Reflective Polarizing Films Market is poised for substantial growth, projected to expand…

5 months ago

Mexico Biostimulants Market Size To See Promising Growth | Projected at USD 155 Million by 2033

Introduction The Mexico Biostimulants Market, valued at USD 48 Million in 2023, is projected to…

5 months ago

Nylon Market Size To Worth USD 60.3 Billion By 2033 | CAGR Of 5.8%.

Introduction The global Nylon Market, valued at USD 34.3 Billion in 2023, is poised for…

5 months ago

Acrylic Acid Market Expected To Reach USD 20.8 Billion in 2033, Set To Surge With a 4.4% CAGR

Introduction The global Acrylic Acid Market, valued at approximately USD 13.5 Billion in 2023, is…

5 months ago